Less Ads, More Data, More Tools Register for FREE

Pin to quick picksAurora Uk Alpha Regulatory News (ARR)

Share Price Information for Aurora Uk Alpha (ARR)

Share Price is delayed by 15 minutes
Get Live Data
241.00    2.00 (0.84%)
Bid:
239.00
Ask:
242.00
Spread: 3.00 (1.255%)
Market Cap: £261.41m
ARR Live PriceLast checked at - London Stock Exchange

Intraday Aurora Uk Alpha Share Chart

Share Buyback

11 Feb 2025 07:00

RNS Number : 5918W
Aurora UK Alpha PLC
11 February 2025
Β 

11 February 2025

Β 

Aurora UK Alpha plc

LEI: 2138007OUWIZFMAGO575

Β 

Share Buyback

Β 

The Board of Aurora UK Alpha plc (the "Company") announces the commencement of a discretionary share buyback programme (the "Share Buyback"), conducted in accordance with existing authorities.

Β 

The Board regularly reviews market conditions and believes that a buyback programme currently offers an attractive use of capital.

Β 

Share repurchases, if implemented, will be conducted in open market transactions and may be made from time to time depending on market conditions, share price, and trading volume. There is no certainty that any buybacks will be completed and may be paused or discontinued at any time.

Β 

The Share Buyback will take place within the limitations of the authority granted to the Board of the Company at its annual general meeting ("General Authority"), held on 12 June 2024, pursuant to which the maximum number of shares which may be bought back is 11,436,279.Β 

Β 

About the Share Buyback

Β 

Β· TheΒ Share BuybackΒ will be financed through the Company's cash resources.

Β· The purchased Ordinary Shares will be held by the Company in treasury at the Company's discretion for later reissue or cancellation.

Β· The Company confirms that it is not in a closed period and currently has no unpublished inside information.

Β· The aggregate number of Ordinary Shares acquired by the Company pursuant to theΒ Share BuybackΒ shall not exceed the maximum number of Ordinary Shares which the Company is authorised to purchase pursuant to the General Authority.

Β· The potential purchase of shares will commence on the date of this announcement and will continue until the earlier of the expiration of the General Authority or until the number of Ordinary Shares equal to the maximum pecuniary amount have been purchased under theΒ Share Buyback or the process is terminated or paused.

Β· Share repurchases, if undertaken, will be conducted at prevailing market prices, subject to a maximum price per share determined in accordance with the General Authority (being no more than 105% of the average middle market closing price over the preceding five business days, and a minimum price of 25 pence per share.

Β· The Company does not intend to rely on the safe harbour provisions dealing with trading for share buyback programmes set out in Article 5 of the Market Abuse Regulation 596/2014/EU (as onshored into UK legislation following Brexit).

Β 

As at 11 February 2025, the Company's total issued share capital consisted of 114,572,742 Ordinary Shares, with one voting right per share. The Company does not as at this date hold any Ordinary Shares in treasury. Therefore, the total number of voting rights in the Company was 114,572,742.

Β 

This announcement contains inside information for the purposes of Article 7 of Market Abuse Regulation (EU) 596/2014 as it forms part of UK domestic law by virtue of the European Union (Withdrawal) Act 2018 as amended, and is disclosed in accordance with the Company's obligations under Article 17 of MAR. The person responsible for arranging for the release of this announcement on behalf of Aurora Investment Trust plc is Frostrow Capital LLP, the Company Secretary.

Β 

Β 

Frostrow Capital LLP

Company Secretary

Tel: 020 3709 8733

Β 

Panmure Liberum Limited

Chris Clarke / Ashwin Kohli

Tel: 020 3100 2000

LEI: 2138007OUWIZFMAGO575

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
Β 
END
Β 
Β 
POSSFWFASEISEIE
Date   Source Headline
18th Mar 20265:05 pmRNSTransaction in Own Shares
18th Mar 202612:43 pmRNSNet Asset Value(s)
17th Mar 202612:25 pmRNSNet Asset Value(s)
16th Mar 20265:40 pmRNSTransaction in Own Shares
16th Mar 202612:08 pmRNSNet Asset Value(s)
13th Mar 20265:16 pmRNSTransaction in Own Shares
12th Mar 20265:06 pmRNSTransaction in Own Shares
11th Mar 20265:07 pmRNSTransaction in Own Shares
11th Mar 20265:07 pmRNSTransaction in Own Shares
10th Mar 20265:18 pmRNSTransaction in Own Shares
9th Mar 20261:10 pmRNSNet Asset Value(s)
6th Mar 20261:12 pmRNSNet Asset Value(s)
5th Mar 20264:52 pmRNSMonthly Fact Sheet as at 28 February 2026
5th Mar 20264:33 pmRNSTransaction in Own Shares
5th Mar 202611:50 amRNSNet Asset Value(s)
4th Mar 20264:05 pmRNSTransaction in Own Shares
4th Mar 20261:10 pmRNSNet Asset Value(s)
3rd Mar 20265:00 pmRNSTransaction in Own Shares
3rd Mar 202612:32 pmRNSNet Asset Value(s)
2nd Mar 20265:01 pmRNSTransaction in Own Shares
2nd Mar 202612:18 pmRNSNet Asset Value(s)
2nd Mar 20269:39 amRNSTotal Voting Rights
27th Feb 20261:26 pmRNSNet Asset Value(s)
27th Feb 20267:00 amRNSTransaction in Own Shares
26th Feb 202611:21 amRNSNet Asset Value(s)
25th Feb 20264:41 pmRNSTransaction in Own Shares
25th Feb 20262:12 pmRNSNet Asset Value(s)
24th Feb 20265:04 pmRNSTransaction in Own Shares
24th Feb 20261:22 pmRNSNet Asset Value(s)
23rd Feb 202611:59 amRNSNet Asset Value(s)
23rd Feb 20269:15 amRNSCompliance with Market Abuse Regulation
20th Feb 202612:47 pmRNSNet Asset Value(s)
19th Feb 202611:09 amRNSNet Asset Value(s)
18th Feb 202612:30 pmRNSNet Asset Value(s)
17th Feb 202611:43 amRNSNet Asset Value(s)
16th Feb 202612:52 pmRNSNet Asset Value(s)
13th Feb 20261:44 pmRNSNet Asset Value(s)
12th Feb 202612:19 pmRNSNet Asset Value(s)
11th Feb 20261:39 pmRNSNet Asset Value(s)
10th Feb 202611:59 amRNSNet Asset Value(s)
9th Feb 20261:32 pmRNSNet Asset Value(s)
6th Feb 20262:06 pmRNSNet Asset Value(s)
5th Feb 202612:08 pmRNSNet Asset Value(s)
4th Feb 20261:36 pmRNSMonthly Fact Sheet as at 31 January 2026
4th Feb 202612:26 pmRNSNet Asset Value(s)
3rd Feb 202611:58 amRNSNet Asset Value(s)
2nd Feb 20261:31 pmRNSNet Asset Value(s)
30th Jan 20261:50 pmRNSNet Asset Value(s)
29th Jan 202611:46 amRNSNet Asset Value(s)
28th Jan 202612:49 pmRNSNet Asset Value(s)

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.